Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for Pulmonary Hypertension Requiring Nitric Oxide
NCT02170519Phase 4Terminated
- Sponsor
- Duke University
- Start
- Sep 2006
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of iloprost in pulmonary hypertension (PH), sponsored by Duke University. Started Sep 2006; status: terminated.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02170519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170519.